151 related articles for article (PubMed ID: 17550935)
1. Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement.
Malerba M; Radaeli A; Ragnoli B; Airo' P; Corradi M; Ponticiello A; Zambruni A; Grassi V
Chest; 2007 Aug; 132(2):575-80. PubMed ID: 17550935
[TBL] [Abstract][Full Text] [Related]
2. Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension.
Rolla G; Colagrande P; Scappaticci E; Chiavassa G; Dutto L; Cannizzo S; Bucca C; Morello M; Bergerone S; Bardini D; Zaccagna A; Puiatti P; Fava C; Cortese G
J Rheumatol; 2000 Jul; 27(7):1693-8. PubMed ID: 10914853
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis.
Tiev KP; Coste J; Ziani M; Aubourg F; Cabane J; Dinh-Xuan AT
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):32-8. PubMed ID: 19960786
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease.
Guillen-Del Castillo A; Sánchez-Vidaurre S; Simeón-Aznar CP; Cruz MJ; Fonollosa-Pla V; Muñoz X
Arch Bronconeumol; 2017 Mar; 53(3):120-127. PubMed ID: 28038794
[TBL] [Abstract][Full Text] [Related]
5. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.
Kharitonov SA; Cailes JB; Black CM; du Bois RM; Barnes PJ
Thorax; 1997 Dec; 52(12):1051-5. PubMed ID: 9516898
[TBL] [Abstract][Full Text] [Related]
6. Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease.
Girgis RE; Gugnani MK; Abrams J; Mayes MD
Am J Respir Crit Care Med; 2002 Jun; 165(12):1587-91. PubMed ID: 12070057
[TBL] [Abstract][Full Text] [Related]
7. [Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].
Hua-Huy T; Rivière S; Tiev KP; Dinh-Xuan AT
Rev Pneumol Clin; 2014 Dec; 70(6):335-42. PubMed ID: 25457218
[TBL] [Abstract][Full Text] [Related]
8. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.
Tiev KP; Cabane J; Aubourg F; Kettaneh A; Ziani M; Mouthon L; Duong-Quy S; Fajac I; Guillevin L; Dinh-Xuan AT
Eur Respir J; 2007 Jul; 30(1):26-30. PubMed ID: 17428812
[TBL] [Abstract][Full Text] [Related]
9. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
[TBL] [Abstract][Full Text] [Related]
10. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis.
Tiev KP; Le-Dong NN; Duong-Quy S; Hua-Huy T; Cabane J; Dinh-Xuan AT
Nitric Oxide; 2009 May; 20(3):200-6. PubMed ID: 19100854
[TBL] [Abstract][Full Text] [Related]
12. Serum surfactant protein D and exhaled nitric oxide as biomarkers of early lung damage in systemic sclerosis.
Benfante A; Messina R; Paternò A; Scichilone N
Minerva Med; 2018 Apr; 109(2):71-78. PubMed ID: 29164837
[TBL] [Abstract][Full Text] [Related]
13. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
[TBL] [Abstract][Full Text] [Related]
14. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma.
Tiev KP; Hua-Huy T; Kettaneh A; Allanore Y; Le-Dong NN; Duong-Quy S; Cabane J; Dinh-Xuan AT
Thorax; 2012 Feb; 67(2):157-63. PubMed ID: 22026971
[TBL] [Abstract][Full Text] [Related]
15. Increased alveolar nitric oxide in early systemic sclerosis.
Wuttge DM; Bozovic G; Hesselstrand R; Aronsson D; Bjermer L; Scheja A; Tufvesson E
Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S5-9. PubMed ID: 21050538
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension complicating connective tissue disease.
Lynch JP; Belperio JA; Saggar R; Fishbein MC; Saggar R
Semin Respir Crit Care Med; 2013 Oct; 34(5):581-99. PubMed ID: 24037627
[TBL] [Abstract][Full Text] [Related]
17. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
18. Study of the Correlation between HRCT Semi-quantitative Scoring, Concentration of Alveolar Nitric Oxide, and Clinical-functional Parameters of Systemic Sclerosis-induced Interstitial Lung Disease.
Hoang-Duc H; Pham-Huy Q; Vu-Minh T; Duong-Quy S
Yale J Biol Med; 2020 Dec; 93(5):657-667. PubMed ID: 33380926
[No Abstract] [Full Text] [Related]
19. Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease.
Moodley YP; Lalloo UG
Chest; 2001 May; 119(5):1449-54. PubMed ID: 11348952
[TBL] [Abstract][Full Text] [Related]
20. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
